• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

银屑病红皮病型发作合并新型冠状病毒肺炎感染：两例报告及文献综述，重点关注银屑病与新型冠状病毒肺炎的相互影响以及疫情带来的特殊挑战

Erythrodermic flare-up of psoriasis with COVID-19 infection: A report of two cases and a comprehensive review of literature focusing on the mutual effect of psoriasis and COVID-19 on each other along with the special challenges of the pandemic.

作者信息

Behrangi Elham, Sadeghzadeh-Bazargan Afsaneh, Salimi Nastaran, Shaka Zoha, Feyz Kazemi Mohammad Hosein, Goodarzi Azadeh

机构信息

Department of Dermatology Rasool Akram Medical Complex Clinical Research Development Center (RCRDC) School of Medicine Iran University of Medical Sciences (IUMS) Tehran Iran.

School of Medicine Iran University of Medical Sciences Tehran Iran.

出版信息

Clin Case Rep. 2022 Apr 20;10(4):e05722. doi: 10.1002/ccr3.5722. eCollection 2022 Apr.

DOI:10.1002/ccr3.5722
PMID:35474976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9019895/
Abstract

The COVID-19 pandemic has been extra challenging for patients with chronic diseases. Psoriasis is one of the chronic conditions that its treatment mostly relies on immunosuppressants. In this study, we report two cases with a long history of psoriasis that COVID-19 infection caused them to undergo erythrodermic psoriasis.

摘要

新型冠状病毒肺炎疫情对慢性病患者来说格外具有挑战性。银屑病是一种慢性病，其治疗大多依赖免疫抑制剂。在本研究中，我们报告了两例有长期银屑病病史的病例，新型冠状病毒肺炎感染致使他们患上了红皮病型银屑病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f5/9019895/146d3ee36b7d/CCR3-10-e05722-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f5/9019895/637e6c7c59bc/CCR3-10-e05722-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f5/9019895/4c75f82b00fb/CCR3-10-e05722-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f5/9019895/146d3ee36b7d/CCR3-10-e05722-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f5/9019895/637e6c7c59bc/CCR3-10-e05722-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f5/9019895/4c75f82b00fb/CCR3-10-e05722-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97f5/9019895/146d3ee36b7d/CCR3-10-e05722-g003.jpg

相似文献

1
Erythrodermic flare-up of psoriasis with COVID-19 infection: A report of two cases and a comprehensive review of literature focusing on the mutual effect of psoriasis and COVID-19 on each other along with the special challenges of the pandemic.银屑病红皮病型发作合并新型冠状病毒肺炎感染：两例报告及文献综述，重点关注银屑病与新型冠状病毒肺炎的相互影响以及疫情带来的特殊挑战
Clin Case Rep. 2022 Apr 20;10(4):e05722. doi: 10.1002/ccr3.5722. eCollection 2022 Apr.
2
An Erythrodermic Psoriasis Flare-Up With Staphylococcus Bacteremia Secondary to COVID-19 Infection: A Case Report.1例继发于新型冠状病毒肺炎感染的红皮病型银屑病发作伴葡萄球菌菌血症：病例报告
Cureus. 2023 Mar 20;15(3):e36418. doi: 10.7759/cureus.36418. eCollection 2023 Mar.
3
Biologics targeting IL-17 and IL-23 maintain stability in patients with psoriasis during COVID-19 infection: a case-control study.靶向IL-17和IL-23的生物制剂在COVID-19感染期间对银屑病患者维持稳定性：一项病例对照研究。
Front Med (Lausanne). 2023 Nov 6;10:1280965. doi: 10.3389/fmed.2023.1280965. eCollection 2023.
4
[Erythrodermic psoriasis after COVID-19].新型冠状病毒肺炎后红皮病型银屑病
Hautarzt. 2022 Feb;73(2):156-159. doi: 10.1007/s00105-021-04931-0. Epub 2021 Dec 14.
5
Erythrodermic psoriasis eruption associated with SARS-CoV-2 vaccination.与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗接种相关的红皮病型银屑病皮疹
Dermatol Ther. 2022 May;35(5):e15380. doi: 10.1111/dth.15380. Epub 2022 Mar 1.
6
COVID-19 and psoriasis: biologic treatment and challenges.COVID-19 与银屑病：生物治疗及挑战
J Dermatolog Treat. 2022 Mar;33(2):699-703. doi: 10.1080/09546634.2020.1789051. Epub 2020 Jul 6.
7
Two cases of Erythrodermic psoriasis treated with Golimumab.两例使用戈利木单抗治疗的红皮病型银屑病病例。
Ann Med Surg (Lond). 2022 Jun 8;78:103961. doi: 10.1016/j.amsu.2022.103961. eCollection 2022 Jun.
8
Biologics for Psoriasis during the COVID-19 Pandemic.新冠疫情期间用于治疗银屑病的生物制剂
J Clin Med. 2021 Mar 30;10(7):1390. doi: 10.3390/jcm10071390.
9
Immunologic Overlap of Helper T-Cell Subtypes 17 and 22 in Erythrodermic Psoriasis and Atopic Dermatitis.辅助性 T 细胞 17 型和 22 型在红皮病型银屑病和特应性皮炎中的免疫重叠。
JAMA Dermatol. 2015 Jul;151(7):753-60. doi: 10.1001/jamadermatol.2015.2.
10
Low-dose Naltrexone: An Alternative Treatment for Erythrodermic Psoriasis.低剂量纳曲酮：红皮病型银屑病的一种替代治疗方法。
Cureus. 2019 Jan 23;11(1):e3943. doi: 10.7759/cureus.3943.

引用本文的文献

1
Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease.新发触发因素背景下的红皮病型银屑病：度普利尤单抗相关及新冠病毒诱导的银屑病性疾病解析
Dermatopathology (Basel). 2025 Jun 9;12(2):17. doi: 10.3390/dermatopathology12020017.
2
Burden of psoriasis in young adults worldwide from the global burden of disease study 2019.全球疾病负担研究 2019 年报告：全球范围内年轻人银屑病的负担。
Front Endocrinol (Lausanne). 2024 Feb 13;15:1308822. doi: 10.3389/fendo.2024.1308822. eCollection 2024.
3
An Erythrodermic Psoriasis Flare-Up With Staphylococcus Bacteremia Secondary to COVID-19 Infection: A Case Report.

本文引用的文献

1
The effect of influenza vaccine on severity of COVID-19 infection: An original study from Iran.流感疫苗对新冠病毒感染严重程度的影响：一项来自伊朗的原创研究。
Med J Islam Repub Iran. 2021 Sep 7;35:114. doi: 10.47176/mjiri.35.114. eCollection 2021.
2
Pansclerotic Morphea Following COVID-19: A Case Report and Review of Literature on Rheumatologic and Non-rheumatologic Dermatologic Immune-Mediated Disorders Induced by SARS-CoV-2.新型冠状病毒肺炎后泛硬化性硬斑病：1例报告及关于严重急性呼吸综合征冠状病毒2诱导的风湿性和非风湿性皮肤免疫介导疾病的文献综述
Front Med (Lausanne). 2021 Oct 20;8:728411. doi: 10.3389/fmed.2021.728411. eCollection 2021.
3
1例继发于新型冠状病毒肺炎感染的红皮病型银屑病发作伴葡萄球菌菌血症：病例报告
Cureus. 2023 Mar 20;15(3):e36418. doi: 10.7759/cureus.36418. eCollection 2023 Mar.
4
SARS-CoV-2 Infection and Vaccination Cutaneous Manifestations for the Inpatient Dermatologist.住院皮肤科医生需了解的新型冠状病毒2型感染与疫苗接种的皮肤表现
Curr Dermatol Rep. 2022;11(4):252-262. doi: 10.1007/s13671-022-00374-5. Epub 2022 Oct 19.
Pediatric COVID-19 patient with exacerbated generalized pustular psoriasis.
患有加重型泛发性脓疱型银屑病的小儿新冠患者。
Rev Soc Bras Med Trop. 2021 Sep 24;54:e0318. doi: 10.1590/0037-8682-0318-2021. eCollection 2021.
4
Severe and life-threatening COVID-19-related mucocutaneous eruptions: A systematic review.严重且危及生命的 COVID-19 相关黏膜皮肤发疹：系统回顾。
Int J Clin Pract. 2021 Dec;75(12):e14720. doi: 10.1111/ijcp.14720. Epub 2021 Sep 28.
5
New onset of mainly guttate psoriasis after COVID-19 vaccination: a case report.新冠病毒疫苗接种后主要新发点滴状银屑病：一例报告
J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e752-e755. doi: 10.1111/jdv.17561. Epub 2021 Aug 4.
6
A systematic review on efficacy, safety, and treatment-durability of low-dose rituximab for the treatment of Pemphigus: special focus on COVID-19 pandemic concerns.一项关于低剂量利妥昔单抗治疗天疱疮的疗效、安全性和治疗持久性的系统评价：特别关注 COVID-19 大流行相关问题。
Immunopharmacol Immunotoxicol. 2021 Oct;43(5):507-518. doi: 10.1080/08923973.2021.1953063. Epub 2021 Jul 21.
7
Histopathologic survey on lung necropsy specimens of 15 patients who died from COVID-19: A large study from Iran with a high rate of anthracosis.对15例死于新型冠状病毒肺炎患者的肺尸检标本进行组织病理学调查：来自伊朗的一项大规模研究，煤尘肺发病率高。
Med J Islam Repub Iran. 2021 May 17;35:63. doi: 10.47176/mjiri.35.63. eCollection 2021.
8
Does methotrexate influence COVID-19 infection? Case series and mechanistic data.甲氨蝶呤是否会影响 COVID-19 感染？病例系列和机制数据。
Arthritis Res Ther. 2021 Jun 10;23(1):166. doi: 10.1186/s13075-021-02464-4.
9
Skin manifestations as potential symptoms of diffuse vascular injury in critical COVID-19 patients.皮肤表现可能是重症 COVID-19 患者弥漫性血管损伤的潜在症状。
J Cutan Pathol. 2021 Oct;48(10):1266-1276. doi: 10.1111/cup.14059. Epub 2021 Jun 15.
10
A systematic review of the histopathologic survey on skin biopsies in patients with Corona Virus Disease 2019 (COVID-19) who developed virus or drug-related mucocutaneous manifestations.一项对 2019 年冠状病毒病（COVID-19）患者发生病毒或药物相关黏膜皮肤表现后行皮肤活检的组织病理学调查的系统回顾。
Exp Dermatol. 2021 Sep;30(9):1233-1253. doi: 10.1111/exd.14384. Epub 2021 May 24.